What is Meldonium?
Meldonium (Mildronate) is an anti-ischemic drug that was added to the
World Anti-Doping Agency’s (WADA) Prohibited List, effective January 1, 2016. Not approved by the U.S. Food and Drug Administration (FDA) and not available in the U.S., meldonium is classified as a non-specified substance in the class of Metabolic Modulators on the WADA Prohibited List.
Outside of the United States, meldonium may be used in a clinical setting for those suffering from heart conditions, such as low blood flow to the heart and angina, as well as neurodegenerative disorders and bronchopulmonary diseases.
In sport, evidence indicates that meldonium may increase endurance, improve rehabilitation following exercise, and enhance activations of the central nervous system. Meldonium may also provide cognitive advantages.